Morgan Stanley Maintains Overweight on Alignment Healthcare, Lowers Price Target to $12
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Ricky Goldwasser maintains an Overweight rating on Alignment Healthcare (NASDAQ:ALHC) but lowers the price target from $19 to $12.
August 30, 2023 | 2:09 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
Morgan Stanley maintains an Overweight rating on Alignment Healthcare but lowers the price target from $19 to $12.
The news is directly related to Alignment Healthcare (ALHC). While the Overweight rating is maintained, indicating a positive outlook, the lowering of the price target from $19 to $12 may create some uncertainty among investors, potentially impacting the stock's short-term performance.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100